A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1994
12/27/1994	US5376647 bisphosphonic acid derivatives, and useful as a bone resorption inhibitor
12/27/1994	US5376645 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
12/27/1994	US5376644 Viricides
12/27/1994	US5376642 Treatment of retroviral induced dementia by administration of 2',3'-dideoxyinosine
12/27/1994	US5376636 Method for promoting tissue repair and regeneration using PDGF and glucocorticoids
12/27/1994	US5376607 Method for controlling moisture by coke composition
12/27/1994	US5376553 Analyzing biological fluid samples for presence of dicitrate cyclic diester which indicates no pathological calcification or predisposition towards it
12/27/1994	US5376547 With modifications in amino acid content which eliminate binding to liver membranes and aid in maintaining concentration in blood
12/27/1994	US5376384 Delayed, sustained-release pharmaceutical preparation
12/27/1994	US5376383 Drug delivery of hydroxy-3-methylglutaryl/3-/coenzyme A reductase inhibitor
12/27/1994	US5376382 Tablets, granulates and pellets with a high active substance content for highly concentrated, solid dosage forms of thioctic acid
12/27/1994	US5376377 Transdermal contraceptive formulations, methods and devices
12/27/1994	US5376371 Topical; extracts from Salvia and Ginkgo leaves with excipient ; adenylate cyclase agonist and phosphodiesterase inhibitor
12/27/1994	US5376365 High visocity isotonic mixture of humectant and high molecular weight anionic polymer
12/27/1994	US5376361 Contains vitamin E enriched with tocotrienols
12/27/1994	US5375693 Methods and compositions for treating allergic disorders and other disorders metabolic derivatives of terfenadine
12/27/1994	US5375611 Chemical modification of the posterior surface of the lens capsule for preventing cell attachment and growth
12/27/1994	CA2126719A1 Piperidines and piperazines
12/27/1994	CA1333714C Quinoline ether alkanoic acids for use as inhibitors of leukotriene biosynthesis
12/26/1994	CA2126363A1 3-hydroxy-4-hydroxymethyl-2-methylenecyclopentyl purines and pyrimidines
12/26/1994	CA2113700A1 2-(3-oxoalk(en)yl)-3-isothiazolones and derivatives as antimicrobial agents
12/25/1994	CA2126400A1 Hypoglycemic agents
12/25/1994	CA2126397A1 4-bicyclically substituted dihydropyridines, processes for their preparation and their use in medicaments
12/23/1994	CA2125238A1 Use of esters of l-carnitine and acyl l-carnitine with hydroxyacids for producing pharmaceutical compositions for treating dermatoses
12/22/1994	WO1994029471A1 Adenoviral vectors for treatment of hemophilia
12/22/1994	WO1994029470A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives
12/22/1994	WO1994029446A2 Intracellular binding proteins and use thereof
12/22/1994	WO1994029444A1 Method for treating kaposi's sarcoma with antisense oligonucleotides
12/22/1994	WO1994029438A1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
12/22/1994	WO1994029404A1 Polyphenol derivative compositions and preparation thereof
12/22/1994	WO1994029348A2 Production of antibody fragments
12/22/1994	WO1994029347A1 Antibody fragments in therapy
12/22/1994	WO1994029336A1 New peptide derivatives
12/22/1994	WO1994029328A1 Antiparasitic agents
12/22/1994	WO1994029320A1 Cephalosporin compound, process for producing the same, and intermediate compound
12/22/1994	WO1994029319A1 14-substituted marcfortines and derivatives useful as antiparasitic agents
12/22/1994	WO1994029318A1 Cephalostatin analogues and their use as anti-tumour agents
12/22/1994	WO1994029312A1 O6-substituted guanine derivatives, a process for their preparation and their use in treating tumour cells
12/22/1994	WO1994029309A1 Spiro-substituted azacycles as neurokinin antagonists
12/22/1994	WO1994029308A1 Lavendamycin analogs, their use and preparation
12/22/1994	WO1994029305A1 N-[[1-[4-(4-fluorophenoxy)butyl]-4-piperidinyl]-n-methylamino]-2-benzothiazolols as class iii antiarrhythmic agents
12/22/1994	WO1994029304A1 Thienylthiazole derivatives
12/22/1994	WO1994029303A1 Heterocyclic chemistry
12/22/1994	WO1994029301A1 Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
12/22/1994	WO1994029299A1 Imidazole lipoxygenase inhibitors
12/22/1994	WO1994029298A1 8-amino-7-chloro-1,4-benzodioxan-5-carboxylic acid, -1-butyl-4-piperidinyl ester as a 5-ht4-receptor antagonist
12/22/1994	WO1994029297A1 2-oxo-1,2,3,4-tetrahydroquinoline derivatives
12/22/1994	WO1994029295A1 Heterocyclic derivatives with immunomodulating activity
12/22/1994	WO1994029292A1 Process for the isolation of lovastatin
12/22/1994	WO1994029291A1 Aniline derivatives
12/22/1994	WO1994029290A1 Secondary amines as antidiabetic and antiobesity agents
12/22/1994	WO1994029289A1 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia
12/22/1994	WO1994029288A1 Δ6,7-taxols antineoplastic use and pharmaceutical compositions containing them
12/22/1994	WO1994029286A1 Analgesic dibenzoxazepines and dibenzothiazepines
12/22/1994	WO1994029280A1 Pyrimidine cyanoguanidines as k-channel blockers
12/22/1994	WO1994029276A1 Arylpyrazole fungicides
12/22/1994	WO1994029275A1 Benz(b)azepine-2,5-diones useful in the treatment of neurodegenerative disorders
12/22/1994	WO1994029274A1 New active compounds
12/22/1994	WO1994029273A1 Bicyclic fibrinogen antagonists
12/22/1994	WO1994029272A1 1-substituted isatin and oxindole derivatives as inhibitors of acetylcholinesterase
12/22/1994	WO1994029262A1 Lipoxin compounds
12/22/1994	WO1994029255A1 Aromatic acetylcholinesterase inhibitors
12/22/1994	WO1994028950A1 Plasma-like solution
12/22/1994	WO1994028938A1 Adenovirus vectors for gene therapy sponsorship
12/22/1994	WO1994028936A1 Process for the preparation of an oral solid dosage form containing diclofenac
12/22/1994	WO1994028913A1 Methods and pharmaceutical compositions useful for treating neurological disorders
12/22/1994	WO1994028911A1 COMPOSITIONS FOR USE IN THE REGULATION OF SUBNORMAL pH VALUES IN THE INTESTINAL TRACT AND FOR TREATMENT OF BOWEL DISEASES
12/22/1994	WO1994028910A1 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose
12/22/1994	WO1994028909A1 Antineoplastic compositions and methods of use
12/22/1994	WO1994028908A2 (phospho)lipids for combatting hepatitis b virus infection
12/22/1994	WO1994028907A2 Use of corrinoids in topical treatment of skin diseases
12/22/1994	WO1994028906A1 Treatment of neonatal hyperbilirubin with metalloporphyrin
12/22/1994	WO1994028905A1 Oestriol-containing hormonal agent for the prophylaxis and treatment of arterial conditions in humans, method of preparing it and its use
12/22/1994	WO1994028904A1 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
12/22/1994	WO1994028903A1 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
12/22/1994	WO1994028902A1 Pyrazolopyrimidinones for the treatment of impotence
12/22/1994	WO1994028901A1 Amino acid derivative
12/22/1994	WO1994028900A1 Methods and compositions for lowering intraocular pressure
12/22/1994	WO1994028899A1 New use of ambasilide
12/22/1994	WO1994028898A1 H2-antagonists as immune stimulants in bacterial infections of cattle or swine
12/22/1994	WO1994028897A2 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection
12/22/1994	WO1994028896A1 Imidazole 5-position substituted angiotensin ii antagonists
12/22/1994	WO1994028895A2 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
12/22/1994	WO1994028894A1 Lotion
12/22/1994	WO1994028893A1 Remedy for systemic autoimmune disease or inflammatory nervous disease
12/22/1994	WO1994028892A1 Inhibitor for rejection accompanying organ transplantation
12/22/1994	WO1994028891A1 Method of treating coronary vascular disease using docosahexaenoic acid
12/22/1994	WO1994028890A1 Drugs, their manufacture and their use to control pain and/or inflammation and/or fever in humans and animals
12/22/1994	WO1994028889A1 Purified natural and synthetic compounds for the treatment of osteoarthritis
12/22/1994	WO1994028888A1 Use of isovaleramide as a mild anxiolytic and mild sedative agent
12/22/1994	WO1994028887A1 Synergistic anthelmintic compositions
12/22/1994	WO1994028886A1 Use of natural products and related synthetic compounds for the treatment of cardiovascular disease
12/22/1994	WO1994028885A1 Diamondoid derivatives for pharmaceutical use
12/22/1994	WO1994028884A1 Zinc monoglycerolate complex for anti-rejection treatment of the human or animal body
12/22/1994	WO1994028883A1 Therapeutic compositions and methods of use
12/22/1994	WO1994028881A1 Delayed release and trapping formulation for a bile acid adsorbent
12/22/1994	WO1994028880A1 Extended release, film-coated tablet of astemizole and pseudoephedrine
12/22/1994	WO1994028873A1 Novel therapeutic drug delivery systems
12/22/1994	WO1994028872A1 Non-alcoholic cold and sinus medication
12/22/1994	WO1994028870A1 Preparations containing silicon dioxide to improve the taste thereof

1 ... 7056 7057 7058 7059 7060 7061 7062 7063 7064 7065 7066 7067 7068 7069 7070 7071 7072 7073 7074 7075 7076 ... 7860